SEARCH

SEARCH BY CITATION

References

  • Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coïc, L., Leveillé, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galactéros, F., Torres, M., Kuentz, M., Ferry, C., Socié, G., Reinert, P. & Delacourt, C. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood, 117, 11301140.
  • Casella, J.F., King, A.A., Barton, B., White, D.A., Noetzel, M.J., Ichord, R.N., Terrill, C., Hirtz, D., McKinstry, R.C., Strouse, J.J., Howard, T.H., Coates, T.D., Minniti, C.P., Campbell, A.D., Vendt, B.A., Lehmann, H. & Debaun, M.R. (2010) Design of the silen\t cerebral infarct transfusion (SIT) trial. Journal of Pediatric Hematology/Oncology, 27, 6989.
  • Coppinger, J.A., O'Connor, R., Wynne, K., Flanagan, M., Sullivan, M., Maguire, P.B., Fitzgerald, D.J. & Cagney, G. (2007) Moderation of the platelet releasate response by aspirin. Blood, 109, 47864792.
  • DeBaun, M.R., Sarnaik, S.A., Rodeghier, M.J., Minniti, C.P., Howard, T.H., Iyer, R.V., Inusa, B., Telfer, P.T., Kirby-Allen, M., Quinn, C.T., Bernaudin, F., Airewele, G., Woods, G.M., Panepinto, J.A., Fuh, B., Kwiatkowski, J.K., King, A.A., Rhodes, M.M., Thompson, A.A., Heiny, M.E., Redding-Lallinger, R.C., Kirkham, F.J., Sabio, H., Gonzalez, C.E., Saccente, S.L., Kalinyak, K.A., Strouse, J.J., Fixler, J.M., Gordon, M.O., Miller, J.P., Noetzel, M.J., Ichord, R.N. & Casella, J.F. (2012) Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood, 119, 36843690.
  • Hillery, C.A., Du, M.C., Wang, W.C. & Scott, J.P. (2000) Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin. British Journal of Haematology, 109, 322327.
  • Kato, G.J., Gladwin, M.T. & Steinberg, M.J. (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews, 21, 3747.
  • Kwiatkowski, J.L., Zimmerman, R.A., Pollock, A.N., Seto, W., Smith-Whitley, K., Shults, J., Blackwood-Chirchir, A. & Ohene-Frempong, K. (2009) Silent infarcts in young children with sickle cell disease. British Journal of Haematology, 146, 300305.
  • Quinn, C.T. & Sargent, J.W. (2008) Daytime steady-state haemoglobin desaturation is a risk factor for overt stroke in children with sickle cell anaemia. British Journal of Haematology, 140, 336339.
  • Quinn, C.T., McKinstry, R.C., Dowling, M.M., Ball, W.S., Kraut, M.A., Casella, J.F., Dlamini, N., Ichord, R.N., Jordan, L.C., Kirkham, F.J., Noetzel, M.J., Roach, E.S., Strouse, J.J., Kwiatkowski, J.L., Hirtz, D. & DeBaun, M.R. (2013) Acute silent cerebral ischemic events in children with sickle cell anemia. JAMA Neurology, 70, 5865.
  • Savage, W.J., Barron-Casella, E., Fu, Z., Dulloor, P., Williams, L., Crain, B.J., White, D.A., Jennings, J.M., Van Eyk, J.E., Debaun, M.R., Everett, A. & Casella, J.F. (2011) Plasma glial fibrillary acidic protein levels in children with sickle cell disease. American Journal of Hematology, 86, 427429.